PM visits 5 facilities, public investments in Alexandria's Borg Al Arab

Wed, 05 Aug 2020 - 08:20 GMT

The construction works of a court that will house Men's Handball World Championship taking place on January 14-31 are completed by 95 percent.

Pharmaceutical sales hit LE 44.7B in 2019

Sun, 17 Nov 2019 - 10:21 GMT

According to pharmaceutical sector data, Egypt's sales recorded EGP 44.7 billion in 2019, with a growth rate of eight percent.

Al Ahram to launch 1st annual conference on pharmaceutical manufacturing

Fri, 15 Nov 2019 - 08:26 GMT

The conference is expected to tackle the pharmaceutical industry in Egypt as a key pillar of the Egyptian national security.

Factories that refuse to withdraw expired drugs to be shut down: Consumer Protection

Fri, 14 Dec 2018 - 11:15 GMT

"Companies are legally obliged to withdraw expired medicines from the market."

Boehringer Ingelheim’s net sales in 2017 exceed 18 billion euros

Wed, 25 Apr 2018 - 08:57 GMT

The research-driven pharmaceutical company Boehringer Ingelheim can look back on a very successful 2017 financial year.

Egypt's ECMI targets 10 pct increase in pharma investments

Wed, 18 Apr 2018 - 03:59 GMT

The Export Council for Medical Industries (ECMI) aims to increase the pharmaceutical sector investments by 5-10 percent within the coming period.

Pharmaceutical investments in Egypt hit LE 120bn: Official

Tue, 12 Dec 2017 - 01:57 GMT

Head of the Federation of Egyptian Chambers of Commerce Ahmed al Wakil said that the value of pharmaceutical investments in Egypt hit 120 billion pounds.

US approves first pill with digital tracking device

Wed, 15 Nov 2017 - 09:31 GMT

US regulators have approved the first pill that contains a digital tracking sensor to alert doctors.

IDA head, Cypriot Medochemie to establish factory in Egypt

Tue, 18 Jul 2017 - 12:04 GMT

Ahmed Abdel Razeq met Tuesday with officials from Medochemie Limited, a Cypriot pharmaceutical company seeking to establish a factory in Egypt.

US panel urges approval of cutting-edge cancer therapy

Thu, 13 Jul 2017 - 11:04 GMT

n advisory panel on Wednesday unanimously urged the US Food and Drug Administration to approve a cutting-edge cancer therapy that genetically alters a patient's .